Evidence map›Paper›PMID 42318312›Full record

ArticleGlobal epidemiology2026

Infection outbreaks caused by carbapenemase-producing Enterobacterales: An epidemiological surveillance study in public hospitals in Chile, 2017-2024.

Cristian Lara, Mauro Orsini, Mónica Pohlenz, Alejandro Guerra, Sofía Kutscher, Carmen Muñoz-Almagro, Pedro Brotons

Abstract read
In one paragraph

Article in Global epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Cristian LaraInfection Control National Programme (PNCI), Ministry of Health Chile, Santiago de Chile, Chile.
Mauro OrsiniInfection Control National Programme (PNCI), Ministry of Health Chile, Santiago de Chile, Chile.
Mónica PohlenzInfection Control National Programme (PNCI), Ministry of Health Chile, Santiago de Chile, Chile.
Alejandro GuerraInfection Control National Programme (PNCI), Ministry of Health Chile, Santiago de Chile, Chile.
Sofía KutscherInfection Control National Programme (PNCI), Ministry of Health Chile, Santiago de Chile, Chile.
Carmen Muñoz-AlmagroDepartment of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain.
Pedro BrotonsDepartment of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Infectious outbreaks caused by carbapenemase-producing Enterobacterales (CPE) in hospitals constitute a global health threat. Objective: To characterise CPE infectious outbreaks in public hospitals in Chile during 2017-2024. Methods: Retrospective epidemiological surveillance study using national public health data across three periods: baseline pre-pandemic (2017-2019), pandemic (2020-2022), and post-pandemic (2023-2024). Results: Seventy-two CPE outbreaks, 945 associated cases and 21 attributable deaths were notified. Median CPE outbreak size in the pre-pandemic period (4 cases) peaked during the pandemic (7 cases) and recovered afterwards post-pandemic (4 cases). Median outbreak duration decreased over time (pre-pandemic period: 75 days; pandemic: 45 days; post-pandemic: 9 days). Conclusions: The size of CPE outbreaks in Chilean public hospitals increased significantly during the pandemic and shrunk back to pre-pandemic values afterwards. CPE outbreak duration decreased sharply from the pandemic onwards. Since 2021, carbapenemases detected in CPE hospital outbreaks have diversified in Chile.

Indexed as

Bacterial drug resistanceCarbapenemsCross infectionEnterobacteralesInfectious disease outbreaks

Identifiers

PMID42318312
PMCPMC13272575

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.